Preventive Healthcare Startup CENT Opens Flagship Clinic in Bengaluru

Why It Matters

By standardising early disease detection in dedicated facilities, CENT could shift India’s healthcare model from reactive treatment to proactive prevention, addressing the rising burden of non‑communicable diseases.

Key Takeaways

• 7,000 sq ft Bengaluru centre offers AI‑driven, two‑hour screenings.
• CCNM Protocol covers cardiac, cancer, neurological, metabolic risks.
• Partnership with Siemens Healthineers enhances imaging efficiency and cost control.
• Goal: 15 cities, 10 million scans, 1 million lives saved by 2035.

Pulse Analysis

India’s preventive‑health market is gaining momentum as non‑communicable diseases surge and affluent consumers seek proactive diagnostics. Traditional labs and hospital check‑up units remain fragmented, offering isolated tests without a unified workflow. This gap creates an opportunity for dedicated prevention centres that can deliver comprehensive, standardized assessments at scale, a niche that CENT is poised to fill.

CENT’s Bengaluru flagship leverages its proprietary CCNM Protocol, an AI‑driven suite that screens cardiac, cancer, neurological and metabolic conditions in a single visit. By integrating whole‑body MRI, low‑dose cardiac CT, DEXA, ECG and more than 120 blood biomarkers, the centre produces a Tru10 organ‑level risk report within two hours, an efficiency rarely seen in India. The partnership with Siemens Healthineers not only supplies state‑of‑the‑art imaging hardware but also co‑develops preventive imaging protocols, driving down per‑scan costs and enhancing diagnostic accuracy.

If CENT can replicate this model across 15 cities, its projected 10 million scans and one‑million lives saved by 2035 could reshape how Indian healthcare is delivered—shifting the focus from treatment to early detection. Investors are likely to watch the rollout closely, as the blend of AI, standardized protocols, and strategic equipment partnerships offers a scalable blueprint for preventive care in emerging markets, though challenges around consumer awareness and reimbursement will need to be addressed.